Does TREPROSTINIL Cause Cardiomyopathy? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Cardiomyopathy have been filed in association with TREPROSTINIL (TYVASO). This represents 0.0% of all adverse event reports for TREPROSTINIL.
12
Reports of Cardiomyopathy with TREPROSTINIL
0.0%
of all TREPROSTINIL reports
4
Deaths
5
Hospitalizations
How Dangerous Is Cardiomyopathy From TREPROSTINIL?
Of the 12 reports, 4 (33.3%) resulted in death, 5 (41.7%) required hospitalization, and 2 (16.7%) were considered life-threatening.
Is Cardiomyopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does TREPROSTINIL Cause?
Dyspnoea (16,348)
Headache (14,051)
Diarrhoea (11,335)
Nausea (10,320)
Cough (8,945)
Fatigue (7,440)
Dizziness (7,405)
Infusion site pain (5,169)
Vomiting (5,097)
Death (4,764)
What Other Drugs Cause Cardiomyopathy?
DOXORUBICIN (820)
CYCLOPHOSPHAMIDE (581)
SACUBITRIL\VALSARTAN (444)
CLOZAPINE (404)
PREDNISONE (379)
RITUXIMAB (379)
ROSIGLITAZONE (374)
VINCRISTINE (326)
TRASTUZUMAB (292)
HYDROXYCHLOROQUINE (231)
Which TREPROSTINIL Alternatives Have Lower Cardiomyopathy Risk?
TREPROSTINIL vs TREPROSTINIL DIOLAMINE
TREPROSTINIL vs TRETINOIN
TREPROSTINIL vs TRIAMCINOLONE
TREPROSTINIL vs TRIAMCINOLONE ACETONIDE
TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE